William B. Walkup & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Buy
27,033
+316
+1% +$37K 1.67% 16
2026
Q1
$2.4M Sell
26,717
-374
-1% -$43.2K 1.43% 19
2025
Q4
$2.85M Buy
27,091
+38
+0.1% +$3.57K 1.56% 16
2025
Q3
$2.27M Buy
27,053
+62
+0.2% +$5.11K 1.22% 24
2025
Q2
$2.14M Buy
26,991
+274
+1% +$21.8K 1.26% 20
2025
Q1
$2.4M Sell
26,717
-161
-0.6% -$15K 1.46% 18
2024
Q4
$2.67M Buy
26,878
+109
+0.4% +$11.2K 1.69% 16
2024
Q3
$3.04M Sell
26,769
-132
-0.5% -$15.7K 1.88% 15
2024
Q2
$3.33M Buy
+26,901
New +$3.47M 2.18% 13

Other funds holding MRK

William B. Walkup & Associates's MRK Position: Q2 2026 in Review

William B. Walkup & Associates increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $37K and bringing the position to 27,033 shares worth $3.47M. The position accounts for 1.67% of the portfolio, ranked #16.

William B. Walkup & Associates first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • William B. Walkup & Associates held 27,033 shares of Merck worth $3.47M as of Q2 2026.
  • William B. Walkup & Associates bought 316 Merck shares in Q2 2026, an estimated $37K.
  • Merck made up 1.67% of William B. Walkup & Associates's portfolio in Q2 2026, its #16 holding.
  • William B. Walkup & Associates first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.